- Home
- GOGO vs ELVN Comparison
GOGO vs ELVN Comparison
Compare GOGO & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOGO | ELVN |
|---|---|---|
| Founded | 1991 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 941.0M | 1.1B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GOGO | ELVN |
|---|---|---|
| Price | $4.61 | $16.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $14.00 | ★ $41.20 |
| AVG Volume (30 Days) | ★ 4.1M | 808.8K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $817,729,000.00 | N/A |
| Revenue This Year | $107.31 | N/A |
| Revenue Next Year | $1.84 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 102.05 | N/A |
| 52 Week Low | $4.49 | $13.30 |
| 52 Week High | $16.82 | $25.37 |
Technical Indicators
Market Signals| Indicator | GOGO | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 21.98 | 39.10 |
| Support Level | $4.49 | $15.71 |
| Resistance Level | $4.81 | $18.05 |
| Average True Range (ATR) | 0.42 | 1.40 |
| MACD | -0.04 | -0.22 |
| Stochastic Oscillator | 4.32 | 16.04 |
Price Performance
Historical ComparisonAbout GOGO Gogo Inc.
Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Gogo BA and Satcom Direct. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.